IL6 and COVID-19: Considering the evidence for the key role of inflammatory markers in exacerbating viral diseases and because COVID-19 is also a viral infectious disease, it can be concluded that the up-regulation of inflammatory cytokines (including CRP, IL-6, and TNF-α) can lead to the progression of the disease to the severe form and eventually cause liver damage in these patients.